Aptahem AB (publ) (APTA.ST)
SEK 1.14
(-0.87%)
SEK 1.14
(-0.87%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.63 Million SEK | 0.0% |
| 2022 | - SEK | 0.0% |
| 2021 | - SEK | 0.0% |
| 2020 | - SEK | 0.0% |
| 2019 | - SEK | -100.0% |
| 2018 | 2906.00 SEK | -47.21% |
| 2017 | 5505.00 SEK | -96.73% |
| 2016 | 168.42 Thousand SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 445 Thousand SEK | 0.0% |
| 2024 Q1 | - SEK | 0.0% |
| 2023 FY | - SEK | 0.0% |
| 2023 Q2 | - SEK | 0.0% |
| 2023 Q3 | - SEK | 0.0% |
| 2023 Q4 | - SEK | 0.0% |
| 2023 Q1 | - SEK | 0.0% |
| 2022 Q2 | - SEK | 0.0% |
| 2022 FY | - SEK | 0.0% |
| 2022 Q4 | - SEK | 0.0% |
| 2022 Q3 | - SEK | 0.0% |
| 2022 Q1 | - SEK | 0.0% |
| 2021 Q3 | - SEK | 0.0% |
| 2021 FY | - SEK | 0.0% |
| 2021 Q2 | - SEK | 0.0% |
| 2021 Q4 | - SEK | 0.0% |
| 2020 FY | - SEK | 0.0% |
| 2019 FY | - SEK | -100.0% |
| 2018 FY | 2906.00 SEK | -47.21% |
| 2017 FY | 5505.00 SEK | -96.73% |
| 2016 FY | 168.42 Thousand SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alligator Bioscience AB (publ) | 58.1 Million SEK | 95.473% |
| Ziccum AB (publ) | 3.74 Million SEK | 29.793% |
| Modus Therapeutics Holding AB (publ) | - SEK | -Infinity% |
| BioArctic AB (publ) | 615.99 Million SEK | 99.573% |
| Sprint Bioscience AB (publ) | 50.48 Million SEK | 94.789% |
| Mendus AB (publ) | 28.48 Million SEK | 90.765% |
| Genovis AB (publ.) | 158.23 Million SEK | 98.337% |
| Intervacc AB (publ) | 8.01 Million SEK | 67.178% |
| QuiaPEG Pharmaceuticals Holding AB (publ) | 4.37 Million SEK | 39.857% |
| Active Biotech AB (publ) | - SEK | -Infinity% |
| Magle Chemoswed Holding AB (publ) | 170.44 Million SEK | 98.457% |
| Bio-Works Technologies AB (publ) | 43.89 Million SEK | 94.007% |
| Vicore Pharma Holding AB (publ) | - SEK | -Infinity% |
| Kancera AB (publ) | 1.03 Million SEK | -154.169% |
| Infant Bacterial Therapeutics AB (publ) | 77 Thousand SEK | -3316.426% |
| Fluicell AB (publ) | 3.33 Million SEK | 21.191% |
| Saniona AB (publ) | 16.84 Million SEK | 84.379% |
| Lipigon Pharmaceuticals AB (publ) | 16.4 Million SEK | 83.966% |
| Biovica International AB (publ) | 7.29 Million SEK | 63.914% |
| Spago Nanomedical AB (publ) | 1.2 Million SEK | -118.674% |
| AcouSort AB (publ) | 10.55 Million SEK | 75.067% |
| Xintela AB (publ) | 78 Thousand SEK | -3272.626% |
| Abliva AB (publ) | 137 Thousand SEK | -1820.181% |
| Egetis Therapeutics AB (publ) | 57.6 Million SEK | 95.433% |
| Karolinska Development AB (publ) | 2.01 Million SEK | -30.618% |
| OncoZenge AB (publ) | 3000.00 SEK | -87588.267% |
| Amniotics AB (publ) | - SEK | -Infinity% |
| 2cureX AB (publ) | 155 Thousand SEK | -1597.192% |
| CombiGene AB (publ) | 5.54 Million SEK | 52.551% |
| Asarina Pharma AB (publ) | - SEK | -Infinity% |
| Calliditas Therapeutics AB (publ) | 1.2 Billion SEK | 99.782% |
| Camurus AB (publ) | 1.71 Billion SEK | 99.847% |
| Corline Biomedical AB | 25.03 Million SEK | 89.49% |
| IRLAB Therapeutics AB (publ) | 5.67 Million SEK | 53.669% |
| Isofol Medical AB (publ) | 721 Thousand SEK | -264.861% |
| I-Tech AB | 120.86 Million SEK | 97.823% |
| Hansa Biopharma AB (publ) | 134.09 Million SEK | 98.038% |
| Cyxone AB (publ) | 5.14 Million SEK | 48.9% |
| ExpreS2ion Biotech Holding AB (publ) | 7.05 Million SEK | 62.686% |
| Biosergen AB | - SEK | -Infinity% |
| Cantargia AB (publ) | - SEK | -Infinity% |
| NextCell Pharma AB | 10.66 Million SEK | 75.333% |
| Xspray Pharma AB (publ) | - SEK | -Infinity% |
| Elicera Therapeutics AB (publ) | 11.23 Million SEK | 76.575% |
| Nanologica AB (publ) | 1.44 Million SEK | -82.304% |
| SynAct Pharma AB | - SEK | -Infinity% |
| Annexin Pharmaceuticals AB (publ) | - SEK | -Infinity% |
| Stayble Therapeutics AB (publ) | - SEK | -Infinity% |
| LIDDS AB (publ) | - SEK | -Infinity% |
| Lipum AB (publ) | 53 Thousand SEK | -4863.487% |
| BioInvent International AB (publ) | 71.46 Million SEK | 96.319% |
| Alzinova AB (publ) | 270 Thousand SEK | -874.314% |
| Oncopeptides AB (publ) | 35.22 Million SEK | 92.531% |
| Pila Pharma AB (publ) | 1.46 Million SEK | -79.809% |
| Guard Therapeutics International AB (publ) | - SEK | -Infinity% |
| Scandinavian ChemoTech AB (publ) | 2.82 Million SEK | 6.781% |
| Simris Alg AB (publ) | 4.35 Million SEK | 39.581% |
| Diamyd Medical AB (publ) | 130 Thousand SEK | -1923.575% |
| Xbrane Biopharma AB (publ) | 238.72 Million SEK | 98.898% |
| Ascelia Pharma AB (publ) | - SEK | -Infinity% |
| Diagonal Bio AB (publ) | 23 Thousand SEK | -11337.6% |